Summary
The effects of chronic administration of (a) 1600 mg. meprobamate, (b) five Tranquil tablets (the maximum recommended daily dose), and (c) placebos were examined, in a counterbalanced partially blinded design. Thirty-two subjects, including 23 anxious patients, employed as their own controls, were given behavioral tests, psychiatric interviews, and ratings at the end of each 21 day treatment period.
On the behavioral tests, meprobamate led to a slowing of reaction time in simulated driving at high speed, accompanied by a slight lowering of accuracy, and an improvement in accuracy of time estimations under a distracting influence. Tranquil led to a similar slowing of reaction time at high speed, along with a nonsignificant tendency toward decreased accuracy, and significantly poorer visual acuity and hyperventilation scores.
On psychiatric evaluations, meprobamate led to marked psychological reactions, daytime sleepiness, longer nighttime sleep, greater restfulness, better retention, need for more physical effort, less tension, decreased appetite, and a feeling that the drug was active. Tranquil led to similar effects as to psychological reactions, daytime sleepiness, nighttime sleep, need for more physical effort, decreased appetite, and judgment of drug activity but no increase in restfulness, improved retention, or lessened tension.
Self-ratings did not differentiate between the three treatments. Ratings by observers indicated decreased anxiety under meprobamate and decreased symptoms under both treatments.
Similar content being viewed by others
References
Cattell, R. B.: Handbook for the objective-analytic personality test batteries. Champaign, Illinois: Institute for Personality and Ability Testing 1955.
Clark, W. C.: Personal communication.
Eysenck, H. J.: Cortical inhibiton, figural after-effect, and theory of personality. J. abnorm. soc. Psychol. 51, 94–106 (1955).
Friedman, M.: Functional cardiovascular disease. Baltimore: Williams & Wilkins Co. 1947.
Hamilton, M.: Psychosomatics. New York: Wiley 1955.
Kelly, E. L., J. G. Miller, D. G. Marquis, R. W. Gerard and L. Uhr: Continued meprobamate and proclorperazine administration and behavior. Arch. Neurol. Psychiat. (Chicago) 80, 247–252 (1958a).
Kelly, E. L., J. G. Miller, D. G. Marquis, R. W. Gerard and L. Uhr: Personality differences and continued meprobamate and proclorperazine administration. Arch. Neurol. Psychiat. (Chicago) 80, 241–246 (1958b).
Kleemeir, R. W., T. A. Rich and W. A. Justiss: The effects of alpha-(2-piperidyl) benzhydryl hydrochloride (Meratran) on psychomotor performance in a group of aged males. J. Geront. 11, 165–170 (1956).
Klein, G. S., and D. Krech: Cortical conductivity in the brain injured. J. Personality 21, 118–148 (1952).
Köhler, W., and H. Wallach: Figural after-effects in kinesthesis, Miscellanea psychologica, edit. by A. Michotte. Louvain: Institut Superior de Philosophie 1947.
Kornetsky, C.: Effects of meprobamate, phenobarbital and dextroamphetamine on reaction time and learning in man. J. Pharmacol. exp. Ther. 123, 216–219 (1958).
Kornetsky, C., O. Humphries and E. V. Evarts: Comparison of psychological effects of certain centrally acting drugs in man. Arch. Neurol. Psychiat. (Chicago) 77, 318–324 (1957).
Lasky, J. J., G. Hover, C. Nord, P. Smith, D. Duffendack and D. W. Bostian: Post hospital adjustment as predicted by staff and by patients. J. cons. Psychol. 23, 213–218 (1959).
Loomis, T. A., and T. C. West: Comparative sedative effects of a barbiturate and some tranquilizer drugs on normal subjects. J. Pharmacol. exp. Ther. 122, 525–531 (1958).
Marquis, D. G., E. L. Kelly, J. G. Miller, R. W. Gerard and A. Rapoport: Experimental studies of behavioral effects of meprobamate on normal subjects. An. N.Y. Acad. Sci. 67, 701–711 (1957).
Melander, B.: Psychotechnological investigation of car drivers in model equipment, translated by the Mental Health Research Institute, Ann Arbor, Michigan, from a duft from the Research Division of A/B Kabi, Stockholm 1957.
Mirsky, I. A., E. Lipman and R. R. Grinker: Breath-holding time in anxiety states. Fed. Proc. 5 (1946).
Nowlis, V., and R. F. Green: A factor analytic study of the domain of mood with independent experimental validation of the factors. Paper read at the Amer. Psychol. Assn., New York, September 1957.
Osgood, C. E.: The nature and measurement of meaning. Psychol. Bull. 49, 197–237 (1952).
Reitan, R. M.: The comparative effects of placebo, Ultran, and meprobamate on psychologic test performance. Antibiot. Med. 4, 158–165 (1957).
Smith, G. W., L. Uhr, J. C. Pollard and J. G. Miller: An exploratory study of the behavioral effects of suavitil (benactyzine hydrochloride). Univ. Mich. med. Bull. 24, 402–427 (1958).
Steinberg, H.: Changes in time perception induced by an anaesthetic drug. Brit. J. Psychol. 46, 273–279 (1955).
Taylor, Janet A.: A personality scale of manifest anxiety. J. abnorm. soc. Psychol. 48, 285–290 (1953).
Uhr, L., and J. G. Miller: An experimental study of the behavioral effects of isothipendyl hydrochloride (Theruhistin). (In press.)
Wechsler, D.: The measurement of adult intelligence, 3rd edit. Baltimore: Williams & Wilkins Co. 1944.
Author information
Authors and Affiliations
Additional information
The authors wish to thank Mr. Gershom Morningstar for conducting the behavioral tests, Drs. Ralph W. Gerard and E. Lowell Kelly for consultation in planning and designing the experiment, Mrs. Mona Morningstar and Messrs. Cameron Yerian and Arthur Platz for help in coding, and Dr. George Fink and The University of Michigan Health Service for referring patients. Partial support and drugs for this study were supplied by the United States Food and Drug Administration, and part from USPHS Grant No. M-1871, Dr. James G. Miller, Principal Investigator.
Rights and permissions
About this article
Cite this article
Uhr, L., Pollard, J.C. & Miller, J.G. Behavioral effects of chronic administration of psychoactive drugs to anxious patients. Psychopharmacologia 1, 150–168 (1959). https://doi.org/10.1007/BF00409114
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00409114